BioCentury
ARTICLE | Financial News

Proteostasis' follow-on brings in $65M

September 9, 2016 7:00 AM UTC

Proteostasis Therapeutics Inc. (NASDAQ:PTI) raised $65 million through the sale of 5 million shares at $13 in a follow-on underwritten by Leerink Partners, RBC Capital Markets, H.C. Wainwright and Baird.

After market hours on Aug. 25, Proteostasis proposed to raise up to $60 million in the offering. Its shares were worth $14.77 at the time. Proteostasis dipped $0.72 to $12.64 on Friday. ...